DARZALEX^® is an intravenous (IV) infusion, given through a needle placed in a vein by a healthcare professional. It may be given alone or with other medicines to treat your multiple myeloma.

Your healthcare professional will determine your dose of DARZALEX^® based on your weight and the time between doses based on which DARZALEX^® regimen you receive.

If you miss an appointment, be sure call your doctor as soon as possible to reschedule.

DARZALEX^® infusion schedules

• I am newly diagnosed and cannot receive a stem cell transplant that uses my own stem cells (autologous stem cell transplant)

  See the DARZALEX^® + Revlimid^® (lenalidomide) + dexmethasone regimenSee the DARZALEX^® + Velcade^® (bortezomib) + melphalan + prednisone regimen

• I am newly diagnosed and can receive a stem cell transplant that uses my own stem cells

  See the DARZALEX^® + Velcade^® (bortezomib) + thalidomide + dexmethasone regimen

• I have received at least one prior medicine to treat my multiple myeloma

  See the DARZALEX^® + Revlimid^® (lenalidomide) + dexamethasone regimenSee the DARZALEX^® + Velcade^® (bortezomib) + dexamethasone regimen

• I have received at least two prior medicines to treat my multiple myeloma, including Revlimid^® (lenalidomide) and a proteasome inhibitor

  See the DARZALEX^® + Pomalyst^® (pomalidomide) + dexamethasone regimen

• I have received at least three prior medicines to treat my multiple myeloma, including a proteasome inhibitor and an immunomodulatory agent, or if a proteasome inhibitor and an immunomodulatory agent did not work for me

  See the DARZALEX^® monotherapy regimen

Your healthcare provider will develop a treatment plan that is suited to your needs. If you have questions about your regimen, follow up with your doctor.

Find out what you can expect before, during, and after a DARZALEX^® infusion